Activation of the EGFR/RAS/p42,44 MAPK axis as a convergent mechanism of resistance to CDK4/6 inhibitors in ER+ breast cancer Meeting Abstract


Authors: De Angelis, C.; Cataldo, M. L.; Nardone, A.; Veeraraghavan, J.; Fu, X.; Nanda, S.; Qin, L.; Sethunath, V.; Pereira, R.; Weigelt, B.; Reis-Filho, J. S.; Rimawi, M. F.; Jeselsohn, R.; Osborne, K.; Schiff, R.
Abstract Title: Activation of the EGFR/RAS/p42,44 MAPK axis as a convergent mechanism of resistance to CDK4/6 inhibitors in ER+ breast cancer
Meeting Title: 42nd Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 80
Issue: 4 Suppl.
Meeting Dates: 2019 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2020-02-01
Language: English
ACCESSION: WOS:000527012503281
DOI: 10.1158/1538-7445.Sabcs19-pd2-02
PROVIDER: wos
Notes: Meeting Abstract: PD2-02 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Britta Weigelt
    646 Weigelt